Drug Information

General Information
Drug ID
DR00412
Drug Name
Efavirenz
Synonyms
(-)-Efavirenz; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben; (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one; DMP 266; DMP-266; EFV; EFZ; Efavirenz (JAN/INN); Efavirenz, (S)-isomer; Eravirenz; L 743726; L-741211; L-743,726; L-743725; L-743726; Met-SDF-1.beta. & Efavirenz; Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz; Stocrin; Stocrin (TN); Strocin (TM); Sustiva; Sustiva (TM); Sustiva (TN); Zoxazin-2-one
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD11: 1C62.Z] Approved [1]
Therapeutic Class
Anti-HIV Agents
Structure
3D MOL 2D MOL
Formula
C14H9ClF3NO2
Canonical SMILES
C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
InChI
InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1
InChIKey
XPOQHMRABVBWPR-ZDUSSCGKSA-N
CAS Number
CAS 154598-52-4
Pharmaceutical Properties Molecular Weight 315.67 Topological Polar Surface Area 38.3
Heavy Atom Count 21 Rotatable Bond Count 1
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 5
XLogP
4
PubChem CID
64139
PubChem SID
10288 , 104234240 , 104330198 , 118313744 , 12014858 , 124658998 , 126592964 , 126608811 , 126622440 , 126654055 , 129722732 , 131300250 , 134337998 , 135022248 , 136367956 , 136903808 , 137005170 , 137229934 , 14850291 , 2102933 , 26719858 , 43121048 , 46386724 , 46392227 , 46392228 , 46506827 , 49681705 , 50064506 , 53788925 , 57315036 , 615076 , 644086 , 78192089 , 7847960 , 7887287 , 7979148 , 8032270 , 8189153 , 819805 , 819816 , 822777 , 822778 , 823557 , 87350529 , 91146581 , 92308418 , 92309272 , 92717165 , 93166541 , 99444180
ChEBI ID
ChEBI:119486
TTD Drug ID
D07HVY
DT(s) Transporting This Drug MRP3 Transporter Info Multidrug resistance-associated protein 3 Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
References
1 Efavirenz was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Induction of multiple drug transporters by efavirenz. J Pharmacol Sci. 2009 Feb;109(2):242-50.
3 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.